Dr Natalie Cook

University of Manchester/Christie NHS Foundation Trust

Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester. She is also the clinical lead for Manchester Experimental Cancer Medicine Centre and is director for the MRes in Experimental Medicine at the University of Manchester. She previously trained in Medical Oncology in Cambridge, UK, where she completed a PhD, funded by a CRUK Clinical Training fellowship. In 2012, she was awarded the Rothwell Jackson Postgraduate Travelling Fellowship and travelled to Canada to undertake a 2 year drug development research fellowship, based at the University of Toronto and Princess Margaret Cancer Centre. In her current position she is co-investigator on a portfolio of over 50 early phase clinical trials, and is a Principal Investigator on over 20 trials.

dont miss

Molecular testing and novel therapies in prostate cancer

This seminar will discuss the increasing use of molecular profiling and identified targets of interest in prostate cancer. It will also cover some aspects of the drug development process and how trial design is changing the route to registration for new therapeutics.

EVEN MORE SEMINARS

  • Rae Denman, and Dr Zoe Poole.: Speaking at the Oncology Convention

    Rae Denman, and Dr Zoe Poole.
    The British Association of Medical Tattooing (BAMT)

    Medical Tattooing: Regulating the industry

  • Mr Hamish Clouston: Speaking at the Oncology Convention

    Mr Hamish Clouston
    The Christie NHS Foundation Trust

    Surgical Management of Advanced Colonic and Rectal Malignancies.

  • Dr Paul Fenton: Speaking at the Oncology Convention

    Dr Paul Fenton
    University Hospital Southampton NHS Foundation Trust

    Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Dr Abeer Shaaban: Speaking at the Oncology Convention

    Dr Abeer Shaaban
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations